Westmount Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,405
Closed -$207K 245
2024
Q4
$207K Buy
2,405
+279
+13% +$24K 0.06% 208
2024
Q3
$253K Buy
2,126
+184
+9% +$21.9K 0.08% 188
2024
Q2
$282K Sell
1,942
-402
-17% -$58.5K 0.09% 165
2024
Q1
$301K Hold
2,344
0.11% 161
2023
Q4
$242K Hold
2,344
0.1% 163
2023
Q3
$213K Buy
+2,344
New +$213K 0.09% 174